Skip to main content

Table 1 Correlation of RCE1 and p-p38 protein expression with clinicopathological parameters

From: Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma

Characteristics n RCE1 P-value P-p38 P-value
Low High Low High
Gender
 Female 96 36 (37.5%) 60 (62.5%) 0.113 43 (44.8%) 53 (55.2%) 0.190
 Male 148 72 (48.6%) 76 (51.4%) 80 (54.1%) 68 (45.9%)
Age (y)
  > 60 105 40 (38.1%) 65 (61.9%) 0.118 51 (48.6%) 54 (51.4%) 0.698
  ≤ 60 139 68 (48.9%) 71 (51.1%) 72 (51.8%) 67 (48.2%)
CEA (ng/ml)
  > 5 116 63 (54.3%) 53 (45.7%) 0.003 67 (58.0%) 49 (42.0%) 0.030
  ≤ 5 128 45 (35.2%) 83 (64.8%) 56 (43.8%) 72 (56.2%)
CA19–9 (U/ml)
  > 37 59 30 (50.8%) 29 (49.2%) 0.107 30 (50.8%) 29 (49.2%) 0.021
  ≤ 37 185 78 (42.2%) 107 (57.8%) 93 (50.3%) 92 (49.7%)
Location
 colon 121 56 (46.3%) 65 (53.7%) 0.797 64 (52.9%) 57 (47.1%) 1.000
 Rectum 123 51 (41.5%) 71 (58.5%) 59 (48.0%) 64 (52.0%)
Depth of invasion
 T1/T2 58 15 (25.9%) 43 (74.1%) 0.001 18 (31.0%) 40 (69.0%) 0.001
 T3/T4 186 93 (48.7%) 93 (51.3%) 105 (56.5%) 81 (43.5%)
Histological grade
 I/II 214 95 (44.4%) 119 (55.6%) 1.000 108 (50.5%) 106(49.5%) 1.000
 III 30 13 (43.3%) 17 (56.7%) 15 (50%) 15(50%)
Node stage
 N0 156 58 (37.2%) 98 (62.8%) 0.000 79 (50.6%) 77 (49.4%) 0.790
 N1 59 26 (44.1%) 33 (55.9%) 28 (47.5%) 31 (52.5%)
 N2 29 24 (82.8%) 5 (17.2%) 16 (55.2%) 13 (44.8%)
TNM stage
 I 48 11 (22.9%) 37 (77.1%) 0.001 17 (35.4%) 37 (64.6%) 0.04
 II 108 48 (44.4%) 60 (55.6%) 62 (57.4%) 46 (42.6%)
 III 88 49 (56.7%) 39 (43.3%) 44 (50%) 44 (50%)
  1. Bold values ( p < 0.05) indicate statistical significance